期刊文献+

高血压相关基因与运动防治的分子生物学基础 被引量:3

Related Genes of Hypertension and Molecule Biology of Exercise Prevention and Cure
下载PDF
导出
摘要 高血压病是一种遗传性疾病,属于复杂性状疾病范畴,是“基因-基因”与“基因-环境”相互作用所致的多基因遗传性疾病。与高血压形成相关的部分基因主要是肾素、血管紧张素原基因、血管紧张素转换酶基因、原癌基因和抑癌基因、血管紧张素II的1型受体、内皮型一氧化氮合酶、α-内收蛋白、G蛋白β3亚基、激肽释放酶。运动防治高血压的分子生物学机理方面的研究还很少,仅仅对高血压某一领域进行了的部分研究、缺乏系统性和深入性。运动防治高血压的效果存在着明显的个体差异。近年来关于高血压个体的训练敏感性与基因多态性之间的研究已有报道,这对阐明运动防治高血压效果的个体差异机理以及制定合理的个性化运动处方很有意义。 Hypertension is a polygene transmissibility illness with complexity trait. It is caused by reciprocity of gene-gene and gene-environment. Related genes of hypertension includes renin, angiotensinoge, tumor suppressor gene and oncogenes, angiotensin Ⅱ type 1 receptor, endothelial nitric oxide synthas, α-adducin, G-protein β3 subunit, kallikrein. At present, there were few molecule biology researches on exercise-preventing and curing hypertension, and the few non-systemic researches investigated some aspects of hypertension and exercise. In addition, effects of exercise on hypertension showed significant individual difference. Recently, there are some reports of exercise-sensitivity of personality and gene polymorphism, which will contribute to mechanism research of effects of exercise on hypertension and make rational and personal exercise prescription.
出处 《体育科学》 CSSCI 北大核心 2007年第2期58-66,共9页 China Sport Science
关键词 高血压 运动 分子生物学 防治 hypertension exercise molecule biology prevention and cure
  • 相关文献

参考文献44

  • 1陆均金,黄其昌.高血压病的基因治疗进展[J].医学综述,2004,10(7):414-416. 被引量:3
  • 2STAMLER J, STAMLER R, NEATON J D, et al. Blood pressure, systolic and diastolic, and cardiovascular risks, CLS population data [J]. Arch Intern Med,1993,153 (5) :598-615.
  • 3LUFT F C. Molecular genetics of human[J]. J Hypertension,1998,16(12) :1781.
  • 4侯嵘 刘治全.高血压遗传机制研究进展.中华心血管病杂志,2001,29(4):251-251.
  • 5陈竺 强伯勤 方得福.基因组科学与人类疾病[J].北京:科学出版社,2002.1-11.
  • 6KRUSHKAL J, HERRELL R, MOCKRIN S C, et al. Genomewide linkage analysis of systolic blood pressure using discordant siblings[J]. Circ, 1999,99 (11) : 1407.
  • 7NIU T,XU X,CORDELL H J,et al. Linkage analysis of candidate genes and gene-gene in Chinese hypertension sib pairs[J]. Hypertension, 1999,33(6) : 1332.
  • 8NAGASE M, KANAME S, NAGASE T, et al. Expression of LOX-1, an oxidized low-density lipoprotein receptor, in experimental hypertensive glomerulosclerosis[J]. J Am Soc Nephrol,2000,11(10) : 1826-1836.
  • 9HILGERS K F. Monocytes/macrophages in hypertension[J]. JHypertens, 2002; 20 (4): 593-596.
  • 10TOMITA N, MORISHITA R, HIGAKI J, et al. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen[J].Hypertension, 1995,26(1): 131-136.

二级参考文献76

  • 1李昭波,高云秋,唐朝枢.运动对自发性高血压大鼠心肌血管紧张素Ⅱ含量的影响[J].体育科学,1997,17(3):69-70. 被引量:11
  • 2李昭波,高云秋,庞永正,刘秀华,唐朝枢.运动性与病理性心肌肥大左室肌球蛋白α和β重链变化比较[J].体育科学,1997,17(1):50-53. 被引量:14
  • 3[1]Mosterd A, D gostino RB, Silbershatz, H ,etal.Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from1950 to 1989 N Engl J Med, 1999,340;1221-1227.
  • 4[2]Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol, 2000,85:251-255.
  • 5[3]Ward R.Familial aggregation and genetic epidemiology of blood pressure. In:Hypertension:pathophysiology, diagnosis and management. Laragh JH,Brenner BM(editors).New York, Raven Press;1990.pp.81-100.
  • 6[4]Luft FC. Molecular genetics of human hypertension.J Hypertens. 1998,16:1871-1878.
  • 7[5]Kunz R, Kreutz R, Beige J, et al. Association between the angiotensinogen 253T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997;30:1331-1337.
  • 8[6]Staessen JA, Kuznetsova T, Wang JG, et al. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999;17:9-17.
  • 9[7]Staessen JA,Wang JG,Ginocchio G,et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15:1579-1592.
  • 10[8]Fomage M, Amos CI, Kardia S, et al. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 1998;97:1773-1779.

共引文献63

同被引文献36

  • 1刘向辉,刘桂华,陈松娥.等张运动与等长运动对高血压患者血脂及内皮素的影响[J].北京体育大学学报,2005,28(2):203-205. 被引量:12
  • 2王先梅,杨丽霞.原发性高血压发病机制的研究进展[J].西南国防医药,2005,15(1):98-100. 被引量:39
  • 3肖夕君.不同强度运动对1级高血压患者疗效的研究[J].中国康复医学杂志,2005,20(5):349-352. 被引量:16
  • 4Karpovich PV. Exercise in medicine: a review [ J ]. Arch Phys Med Rehabil, 1968, 49 (2): 66-76.
  • 5Wallace JP. Exercise in hypertension. A clinical review [ J ]. Sports Med, 2003, 33 (8): 585-598.
  • 6Ramsay LE, Haq IU, Yeo WW, et al. Might non - pharmacological treatment disadvantage patients with hypertension [ J ]. J Hum Hypertens, 1995, 9 (8): 653-657.
  • 7Lurbe E, Torro I, Rodriguez C, et al. Birth weight influences blood pressure values and varlahillty in children and adolescents [ J J. Hypertension, 2001, 38 (3): 389-393.
  • 8Stamler J, Stamler R, Neaton JD, et al. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data [ J ]. Arch Intem Med, 1993, 153 (5) : 598 -615.
  • 9Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients [ J ]. Circulation, 2001, 104 (2): 191-196.
  • 10Schiffrin EL Vascular endothelin in hypertension [ J ]. Vascul Pharmacol, 2005, 43 (1) : 19-29.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部